SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
141 hedge funds and large institutions have $448M invested in SANGAMO THERAPEUTICS INC in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 20 closing their positions.
838% more call options, than puts
Call options by funds: $28.4M | Put options by funds: $3.02M
51% more capital invested
Capital invested by funds: $297M → $448M (+$151M)
10% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 20
0% more funds holding
Funds holding: 141 → 141 (0)
14% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$11.8M |
| 2 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$6.55M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$5.91M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.41M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$2.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$18.3M |
| 2 |
Goldman Sachs
New York
|
-$6.39M |
| 3 |
Millennium Management
New York
|
-$5.19M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.95M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$2.72M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QIM
151
Quantitative Investment Management
Charlottesville,
Virginia
| – | -$254K | -45,100 | Closed |
|
|
AC
152
Amici Capital
New York
| – | -$226K | -40,000 | Closed |
|
153
LPL Financial
San Diego,
California
| – | -$200K | -32,835 | Closed |
|
|
AIM
154
Ada Investment Management
New York
| – | -$118K | -20,845 | Closed |
|
|
DIA
155
Denver Investment Advisors
Denver,
Colorado
| – | -$81K | -14,314 | Closed |
|
|
QT
156
Quantbot Technologies
New York
| – | -$31.9K | -4,136 | -98% |
|
|
PCM
157
Prelude Capital Management
New York
| – | -$20K | -3,517 | Closed |
|
|
PSI
158
Pinnacle Summer Investments
Fairfax,
Virginia
| – | -$8K | -1,500 | Closed |
|
|
BCM
159
Brookstone Capital Management
Wheaton,
Illinois
| – | -$3K | -500 | Closed |
|
|
LFR
160
Lehman Financial Resources
Media,
Pennsylvania
| – | -$1K | -200 | Closed |
|
|
RPG
161
Risk Paradigm Group
Austin,
Texas
| – | -$649 | -115 | Closed |
|
SGMO Hedge Fund Activity: Q4 2015 in Review
141 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2015, worth a combined $448M — up 51% from $297M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SGMO positions and 20 closed out — a net gain of 2 holders — while 38 added to existing stakes and 44 trimmed.
The largest buyer was Balyasny Asset Management, adding an estimated $11.8M. The largest seller was State Street, cutting an estimated $18.3M.
- 141 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $448M of SANGAMO THERAPEUTICS INC stock for Q4 2015, up 51% quarter-over-quarter.
- 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2015 and 20 closed out, a net change of +2 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q4 2015 was Balyasny Asset Management, an estimated $11.8M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q4 2015 was State Street, an estimated $18.3M sold.
Based on aggregated 13F filings for Q4 2015.